Biotech | September 09, 2021
Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.
HTL will build, validate and operate a botulinum manufacturing facility in the US
HTL will build, validate and operate a botulinum manufacturing facility in the US
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency
The facility has the capacity to produce one crore doses per day
The company to receive upfront and milestone payments, in addition to royalties
This is the first of its kind vaccine for Covid 19 to get the go-ahead
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
A veteran in cell therapy and oncology commercialisation
CDSCO to fast-track trials and approval for COVID19 vaccine
Subscribe To Our Newsletter & Stay Updated
